Morus alba Leaf Bioactives Modulate Peroxisome Proliferator Activated Receptor γ in the Kidney of Diabetic Rat and Impart Beneficial Effect
- 3 July 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 66 (30) , 7923-7934
Abstract
Peroxisome proliferator activated receptor gamma (PPARү) are ligand-activated nuclear receptors that can be activated or repressed by several exogenous and endogenous ligands and act by modulating genes which regulate lipid, glucose, and insulin homeostasis. In kidney, they are involved in normal kidney development and other physiological functions. In our earlier report, we showed that feeding Morus alba leaves to experimental diabetic rats ameliorated diabetic nephropathy and significantly decreased microalbuminuria. In this paper, we have attempted to look into the molecular mechanism involving PPARү modulation by mulberry leaf bioactives by in vitro and in vivo methods and its impact on key molecules of inflammatory markers. In vitro assay by TR-FRET suggested that mulberry leaf extracts can serve as putative modulator of PPARү. High glucose conditions in vitro and in vivo increased PPARү levels which were ameliorated by mulberry leaves or its extracts. Interestingly, PPARү was significantly phosphorylated at Ser112 by upstream kinases ERK42/44 in kidney of diabetic animals on feeding mulberry leaves. In vitro studies using MDCK cell line revealed that increased Ser112 phosphorylation was observed when treated with bound phenolic acid rich- extract but not with free phenolic acid-rich extracts. HPLC analysis and bioassay-guided activity revealed that coumaric acid was the bioactive molecule amongst bound phenolic acid-rich extract that was responsible for increased ERK 42/44-mediated phosphorylation at Ser112. Furthermore, mulberry leaf bioactives showed beneficial effect on the tested inflammatory markers.Keywords
Funding Information
- Indian Council of Medical Research
- Council of Scientific and Industrial Research
This publication has 37 references indexed in Scilit:
- Enhancing Pancreatic Beta-Cell Regeneration In Vivo with Pioglitazone and AlogliptinPLOS ONE, 2013
- Food Insecurity and Glycemic Control Among Low-Income Patients With Type 2 DiabetesDiabetes Care, 2012
- PPARγ-Independent Increase in Glucose Uptake and Adiponectin Abundance in Fat CellsEndocrinology, 2011
- Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5Nature, 2010
- Ciglitazone, a PPARγ agonist, ameliorates diabetic nephropathy in part through homocysteine clearanceAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- PPARγ in Kidney Physiology and PathophysiologyPPAR Research, 2008
- Modulation of PPAR activity via phosphorylationBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- PPARs and molecular mechanisms of transrepressionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Adipocytes as regulators of energy balance and glucose homeostasisNature, 2006
- The effect of high glucose and PPAR-γ agonists on PPAR-γ expression and function in HK-2 cellsAmerican Journal of Physiology-Renal Physiology, 2004